The first molecular diagnostic test for the detection of endometrial cancer developed by GEADIC Biotec AIE, joint venture between Oryzon Genomics & Reig Jofre, has been launched in Spain using a business model based on a central laboratory.
GynEC®-DX launched in Spain
